Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Controlled Release

• Publication date

  2015-01-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2014.11.019PMID 25481438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice.

  2013cited by this paper
• Structural modification of siRNA for efficient gene silencing.

  2013cited by this paper
• Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment.

  2013cited by this paper
• Recent attempts at RNAi‐mediated P‐glycoprotein downregulation for reversal of multidrug resistance in cancer

  2013cited by this paper
• Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice.

  2013cited by this paper
• Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs

  2012cited by this paper
• Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.

  2012cited by this paper
• Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.

  2012cited by this paper
• siRNA-Mediated Down-Regulation of P-glycoprotein in a Xenograft Tumor Model in NOD-SCID Mice

  2011cited by this paper
• Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin.

  2011cited by this paper
• The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy.

  2011cited by this paper
• Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for efficient gene silencing.

  2010cited by this paper
• Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing.

  2010cited by this paper
• The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

  2010cited by this paper
• Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1

  2010cited by this paper
• The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.

  2010cited by this paper
• Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma

  2010cited by this paper
• Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells

  2009cited by this paper
• Coadministration of glycolipid-like micelles loading cytotoxic drug with different action site for efficient cancer chemotherapy

  2009cited by this paper
• Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.

  2009cited by this paper
• Doxorubicin‐Conjugated Immuno‐Nanoparticles for Intracellular Anticancer Drug Delivery

  2009cited by this paper
• Sticky overhangs enhance siRNA-mediated gene silencing

  2007cited by this paper
• Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes

  2006cited by this paper
• Characterization of folate-chitosan-DNA nanoparticles for gene therapy.

  2006cited by this paper
• A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System

  2006cited by this paper
• Fluoxetine Inhibits Multidrug Resistance Extrusion Pumps and Enhances Responses to Chemotherapy in Syngeneic and in Human Xenograft Mouse Tumor Models

  2004influential reference
• An algorithm for selection of functional siRNA sequences.

  2004cited by this paper
• Effect of Blood Collection Technique in Mice on Clinical Pathology Parameters

  2002cited by this paper
• Drugs as P-glycoprotein substrates, inhibitors, and inducers

  2002cited by this paper
• Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials

  1999cited by this paper
• P-glycoprotein, multidrug resistance and tumor progression

  1994cited by this paper
• Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.

  1993cited by this paper
• Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration.

  1991cited by this paper
• Cyclosporin A – Usefulness, Risks and Mechanism of Action

  1982cited by this paper
• Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

  1981cited by this paper

• Immunogenic cell death: A promising mechanism involving different therapeutic strategies for liver cancer

  2025cites this paper
• Chemically Cross-Linked Nanocapsules from Terpolymers of Polyethylene Glycol-Polylactide with Cationic Pendent Groups for Pgp-siRNA and Doxorubicin Codelivery in Overcoming Multidrug Resistance in Breast Cancer

  2025cites this paper
• A comprehensive review on overcoming the multifaceted challenge of cancer multidrug resistance: The emerging role of mesoporous silica nanoparticles.

  2025cites this paper
• Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy.

  2024cites this paper
• Chitosan-based nanoarchitectures for siRNA delivery in cancer therapy: A review of pre-clinical and clinical importance.

  2024cites this paper
• Chitosan-based smart stimuli-responsive nanoparticles for gene delivery and gene therapy: Recent progresses on cancer therapy.

  2024cites this paper
• Fabrication of D-α-tocopheryl polyethylene glycol 1000 succinates and human serum albumin conjugated chitosan nanoparticles of bosutinib for colon targeting application; in vitro-in vivo investigation.

  2023cites this paper
• Insights on the Role of Polyphenols in Combating Cancer Drug Resistance

  2023cites this paper
• Chitosan-based bio(nano)platforms and hydrogels in breast cancer therapy: immunotherapy, phototherapy and stimuli-responsive devices.

  2023cites this paper
• Recent Advances in Engineering Carriers for siRNA Delivery.

  2023cites this paper
• All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy

  2023cites this paper
• Investigation of the Adsorption and Release Kinetics of the Anticancer Drug, Methotrexate, From Chitosan Nanocapsules Modified By Caffeic Acid and Oleic Acid

  2023cites this paper
• Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges

  2023cites this paper
• Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy

  2023cites this paper
• Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance.

  2023cites this paper
• PEGylated Reduced Graphene Oxide as Nanoplatform for Targeted Gene and Drug Delivery

  2023cites this paper
• Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems.

  2023cites this paper
• Supramolecular hydrogel for programmable delivery of therapeutics to cancer multidrug resistance.

  2023cites this paper
• Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy.

  2023cites this paper
• Synthesis of Novel Nano-radiotracer for In-vivo Molecular SPECT Imaging: Nanosize Chitosan and its Conjugation with Glutamine

  2023cites this paper
• DNA self-assembly nanoflower reverse P-glycoprotein mediated drug resistance in chronic myelogenous leukemia therapy

  2023cites this paper
• Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment

  2023cites this paper
• Polysaccharide-based nanoassemblies: From synthesis methodologies and industrial applications to future prospects.

  2023cites this paper
• Recent advances in anti-multidrug resistance for nano-drug delivery system

  2022cites this paper
• Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance

  2022cites this paper
• Current advancements in self-assembling nanocarriers-based siRNA delivery for cancer therapy.

  2022cites this paper
• Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy.

  2022cites this paper
• Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

  2022cites this paper
• Evaluation of Sinapic Acid to Ameliorate Ionizing Radiation Induced Peripheral Blood Mononuclear Cell Death

  2022cites this paper
• Nanostructured particles assembled from natural building blocks for advanced therapies.

  2022cites this paper
• Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy.

  2021cites this paper
• Chitosan: A versatile bio-platform for breast cancer theranostics.

  2021cites this paper
• Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance

  2021cites this paper
• P-glycoprotein suppression by photothermal-responsive nitric oxide releasing nanoplatform for triple-combination therapy of multidrug resistant cancer

  2021cites this paper
• Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy.

  2021cites this paper
• Thiolated-Polymer-Based Nanoparticles as an Avant-Garde Approach for Anticancer Therapies—Reviewing Thiomers from Chitosan and Hyaluronic Acid

  2021cites this paper
• Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics.

  2021cites this paper
• The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy.

  2021cites this paper
• Nanomedicines for combating multidrug resistance of cancer.

  2021cites this paper
• A tumor-activatable peptide supramolecular nanoplatform for the delivery of dual-gene targeted siRNAs for drug-resistant cancer treatment.

  2021cites this paper
• NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer.

  2021cites this paper
• Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics

  2020cites this paper
• Capsaicin-Loaded Chitosan Nanocapsules for wtCFTR-mRNA Delivery to a Cystic Fibrosis Cell Line

  2020cites this paper
• Tumor‐Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity

  2020cites this paper
• Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan-Based Nanocarriers.

  2020cites this paper
• Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer

  2020cites this paper
• Rutin- serum albumin interaction in different media and its effective dose selection in radiation-induced cytotoxicity on human blood cells

  2020cites this paper
• PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P‐glycoprotein‐mediated multidrug resistance

  2020cites this paper
• Novel Chitosan Derivatives with Reversible Cationization and Hydrophobicization for Tumor Cytoplasm-Specific Burst Co-delivery of siRNA and Chemotherapeutics.

  2020cites this paper
• Cancer Fighting SiRNA-RRM2 loaded nanorobots.

  2020cites this paper
• Chitosan as a Universal Drug Delivery Vehicle

  2020cites this paper
• Thiolated Chitosans: A Multi-talented Class of Polymers for Various Applications

  2020cites this paper
• Nanomedicine solutions to intricate physiological-pathological barriers and cellular factors of tumor multidrug resistance.

  2020cites this paper
• Chitosan-based Colloidal Polyelectrolyte Complexes for Drug Delivery: A Review.

  2020cites this paper
• Overcoming efflux transporter-mediated resistance in cancer by using nanomedicines

  2020cites this paper
• Photosensitizer-Doped and Plasma Membrane-Responsive Liposomes for Nuclear Drug Delivery and Multidrug Resistance Reversal.

  2020cites this paper
• The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance.

  2020cites this paper
• Aptamer-Functionalized DNA Origami for Targeted Co-delivery of Antisense Oligonucleotides and Doxorubicin to Enhance Therapy in Drug-Resistant Cancer Cells.

  2019cites this paper
• Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency

  2019cites this paper
• Enhancing Systemic Delivery of Enzymatically Generated RNAi Nanocomplexes for Cancer Therapy

  2019cites this paper
• Synthesis of CdS-modified chitosan quantum dots for the drug delivery of Sesamol.

  2019cites this paper
• Drug Targeting Strategies Based on Charge Dependent Uptake of Nanoparticles into Cancer Cells.

  2019influential citation
• Enzyme Immobilization on Chitin and Chitosan-Based Supports for Biotechnological Applications

  2019cites this paper
• Recent Advances in Chitosan-Based Carriers for Gene Delivery

  2019cites this paper
• Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux

  2019cites this paper
• Chitosan for gene, DNA vaccines, and drug delivery

  2019cites this paper
• Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics

  2019cites this paper
• Photoacoustic imaging of cancer cells with glycol-chitosan-coated gold nanoparticles as contrast agents

  2019cites this paper
• Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

  2019cites this paper
• Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.

  2019cites this paper
• Glycol Chitosan: A Water-Soluble Polymer for Cell Imaging and Drug Delivery

  2019cites this paper
• Editorial focus: understanding off-target effects as the key to successful RNAi therapy

  2019cites this paper
• Curcumin increases the sensitivity of K562/DOX cells to doxorubicin by targeting S100 calcium-binding protein A8 and P-glycoprotein

  2019cites this paper
• Functional Chitosan: Drug Delivery and Biomedical Applications

  2019cites this paper
• Dual strategies to correct abnormal ion transports in cystic fibrosis using construct therapy

  2019cites this paper
• Chitosan-Based Systems for Gene Delivery

  2019cites this paper
• Chitosan-Based Systems for Theranostic Applications

  2019cites this paper
• Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation.

  2018cites this paper
• Paraptosis-Inducing Nanomedicine Overcomes Cancer Drug Resistance for a Potent Cancer Therapy.

  2018cites this paper
• Role of Bcl-2 antisense oligonucleotides coated by ultrasound microbubble contrast agents in multidrug-resistant MCF-7/ADM breast cancer cells under ultrasonic irradiation

  2018cites this paper
• Size-controllable dual drug-loaded silk fibroin nanospheres through a facile formation process.

  2018cites this paper
• Construction of a Biomimetic Magnetosome and Its Application as a SiRNA Carrier for High‐Performance Anticancer Therapy

  2018cites this paper
• siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin

  2018cites this paper
• Fabrication of ultrasmall WS2 quantum dots-coated periodic mesoporous organosilica nanoparticles for intracellular drug delivery and synergistic chemo-photothermal therapy

  2018cites this paper
• Targeting nanocarriers containing antisense oligonucleotides to cancer cell

  2017cites this paper
• Cholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene

  2017cites this paper
• Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.

  2017cites this paper
• Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.

  2017cites this paper
• In vitro evaluation of the efficacy of selected medicinal plant extracts against multidrug resistant cancer cells

  2017cites this paper
• Chitosan-based delivery of gene therapeutics for cancer

  2017cites this paper
• Hybrid polysaccharide-based systems for biomedical applications

  2017cites this paper
• Folate-conjugated pH-responsive nanocarrier designed for active tumor targeting and controlled release of doxorubicin

  2017cites this paper
• Progress in gene therapy for breast cancer and what comes next ?

  2017cites this paper
• Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.

  2017cites this paper
• Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer

  2017cites this paper
• Facial Layer-by-Layer Engineering of Upconversion Nanoparticles for Gene Delivery: Near-Infrared-Initiated Fluorescence Resonance Energy Transfer Tracking and Overcoming Drug Resistance in Ovarian Cancer.

  2017cites this paper
• Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance.

  2017cites this paper
• In vitro evaluation of glycol chitosan based formulations as oral delivery systems for efflux pump inhibition.

  2017cites this paper
• Polysaccharide-based Nanoparticles for Gene Delivery

  2017cites this paper
• Chitosan nanoparticle-mediated co-delivery of shAtg-5 and gefitinib synergistically promoted the efficacy of chemotherapeutics through the modulation of autophagy

  2017cites this paper